Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA: TriLipix may not cut patients' heart risks
FDA: TriLipix may not cut patients' heart risks
FDA: TriLipix may not cut patients' heart risks
Submitted by
admin
on November 10, 2011 - 1:21pm
Source:
Fierce Pharma
News Tags:
FDA
TriLipix
fibrates
Abbott Laboratories
Headline:
FDA: TriLipix may not cut patients' heart risks
Do Not Allow Advertisers to Use My Personal information
